Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (331)
SOLENO THERAPEUTICS INC (SLNO)
Huang Michael F. — Sr. VP of Clinical Development
Shares
488
Price
$31.72
Total Value
$15.48K
Shares Held After
39,823
% of Holdings
1.2%
SOLENO THERAPEUTICS INC (SLNO)
Huang Michael F. — Sr. VP of Clinical Development
Shares
1,838
Price
$31.04
Total Value
$57.05K
Shares Held After
40,311
% of Holdings
4.4%
SOLENO THERAPEUTICS INC (SLNO)
Huang Michael F. — Sr. VP of Clinical Development
Shares
4,256
Price
$30.04
Total Value
$127.84K
Shares Held After
42,149
% of Holdings
9.2%
SOLENO THERAPEUTICS INC (SLNO)
Manning Meredith — Chief Commercial Officer
Shares
558
Price
$31.72
Total Value
$17.70K
Shares Held After
64,507
% of Holdings
0.9%
SOLENO THERAPEUTICS INC (SLNO)
Manning Meredith — Chief Commercial Officer
Shares
2,100
Price
$31.04
Total Value
$65.18K
Shares Held After
65,065
% of Holdings
3.1%
SOLENO THERAPEUTICS INC (SLNO)
Manning Meredith — Chief Commercial Officer
Shares
4,864
Price
$30.04
Total Value
$146.10K
Shares Held After
67,165
% of Holdings
6.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
16,322
Price
$13.48
Total Value
$220.02K
Shares Held After
464,554
% of Holdings
3.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
2,738
Price
$12.49
Total Value
$34.20K
Shares Held After
480,876
% of Holdings
0.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
2,329
Price
$450.95
Total Value
$1.05M
Shares Held After
33,076
% of Holdings
6.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
17,470
Price
$4.75
Total Value
$82.98K
Shares Held After
514,621
% of Holdings
3.3%
Mineralys Therapeutics, Inc. (MLYS)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
310,700
Price
$23.67
Total Value
$7.35M
Shares Held After
5,767,221
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$534.50
Total Value
$85.52K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$533.85
Total Value
$234.89K
Shares Held After
40,673
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
720
Price
$532.50
Total Value
$383.40K
Shares Held After
41,113
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
634
Price
$531.32
Total Value
$336.85K
Shares Held After
41,833
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
903
Price
$530.45
Total Value
$478.99K
Shares Held After
42,467
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
841
Price
$529.09
Total Value
$444.96K
Shares Held After
43,370
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
326
Price
$528.30
Total Value
$172.23K
Shares Held After
44,211
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
314
Price
$527.30
Total Value
$165.57K
Shares Held After
44,537
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
104
Price
$526.27
Total Value
$54.73K
Shares Held After
44,851
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,338
Price
$524.80
Total Value
$702.18K
Shares Held After
44,955
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,809
Price
$523.88
Total Value
$947.69K
Shares Held After
46,293
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,514
Price
$522.98
Total Value
$791.80K
Shares Held After
48,102
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
397
Price
$522.10
Total Value
$207.28K
Shares Held After
49,616
% of Holdings
0.8%
Immunome Inc. (IMNM)
SIEGALL CLAY B — Director
Shares
25,450
Price
$19.67
Total Value
$500.60K
Shares Held After
690,704
% of Holdings
3.7%
IMPACT BIOMEDICAL INC. (IBO)
Macko Todd D — Chief Financial Officer
Shares
43,400
Price
$0.56
Total Value
$24.37K
Shares Held After
155,122
% of Holdings
21.9%
Wave Life Sciences Ltd. (WVE)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
2,495,623
Price
$6.43
Total Value
$16.05M
Shares Held After
26,004,414
% of Holdings
9.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
1,973
Price
$37.13
Total Value
$73.26K
Shares Held After
2,188,935
% of Holdings
0.1%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
30,176
Price
$36.38
Total Value
$1.10M
Shares Held After
2,190,908
% of Holdings
1.4%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
30,401
Price
$35.42
Total Value
$1.08M
Shares Held After
2,221,084
% of Holdings
1.4%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
6,735
Price
$30.98
Total Value
$208.64K
Shares Held After
9,597
% of Holdings
41.2%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
9,623
Price
$30.98
Total Value
$298.10K
Shares Held After
16,332
% of Holdings
37.1%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
10,000
Price
$136.82
Total Value
$1.37M
Shares Held After
642,567
% of Holdings
1.5%
LABCORP HOLDINGS INC. (LH)
Meltzer Jonathan C — EVP, Operations
Shares
839
Price
$267.05
Total Value
$224.05K
Shares Held After
3,620
% of Holdings
18.8%
CHEMED CORP (CHE)
MCNAMARA KEVIN J — Director
Shares
1,500
Price
$369.37
Total Value
$554.05K
Shares Held After
92,219
% of Holdings
1.6%
LABCORP HOLDINGS INC. (LH)
Wilkinson Peter J — SVP, Chief Accounting Officer
Shares
1,633
Price
$267.05
Total Value
$436.09K
Shares Held After
1,852
% of Holdings
46.9%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
500,000
Price
$1.35
Total Value
$675.00K
Shares Held After
9,393,276
% of Holdings
5.3%
LENZ Therapeutics, Inc. (LENZ)
Chevallard Daniel R. — Chief Financial Officer
Shares
7,500
Price
$8.57
Total Value
$64.28K
Shares Held After
12,886
% of Holdings
58.2%
LENZ Therapeutics, Inc. (LENZ)
George Jeffrey P. — Director
Shares
5,592
Price
$8.92
Total Value
$49.89K
Shares Held After
5,592
% of Holdings
100.0%
LENZ Therapeutics, Inc. (LENZ)
Schimmelpennink Evert B. — Director
Shares
28,089
Price
$8.95
Total Value
$251.41K
Shares Held After
77,289
% of Holdings
36.3%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
100
Price
$65.99
Total Value
$6.60K
Shares Held After
495,965
% of Holdings
0.0%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
3,038
Price
$65.20
Total Value
$198.07K
Shares Held After
496,065
% of Holdings
0.6%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
3,155
Price
$64.19
Total Value
$202.52K
Shares Held After
499,103
% of Holdings
0.6%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
2,592
Price
$63.35
Total Value
$164.20K
Shares Held After
502,258
% of Holdings
0.5%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
1,012
Price
$62.15
Total Value
$62.90K
Shares Held After
504,850
% of Holdings
0.2%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
550
Price
$60.63
Total Value
$33.34K
Shares Held After
505,862
% of Holdings
0.1%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
490
Price
$59.62
Total Value
$29.22K
Shares Held After
506,412
% of Holdings
0.1%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
3,662
Price
$58.62
Total Value
$214.65K
Shares Held After
506,902
% of Holdings
0.7%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
2,570
Price
$57.91
Total Value
$148.82K
Shares Held After
510,564
% of Holdings
0.5%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
510
Price
$56.61
Total Value
$28.87K
Shares Held After
513,134
% of Holdings
0.1%
Showing 51–100 of 331 transactions (page 2 of 7)